age
float64 18
102
| sex
stringclasses 2
values | hospdead
int64 0
1
| slos
int64 3
343
| dzgroup
stringclasses 8
values | dzclass
stringclasses 4
values | num.co
int64 0
9
| edu
float64 0
31
⌀ | income
stringclasses 4
values | scoma
float64 0
100
⌀ | charges
float64 1.17k
1.44M
⌀ | totcst
float64 0
633k
⌀ | totmcst
float64 -102.72
711k
⌀ | avtisst
float64 1
83
⌀ | race
stringclasses 5
values | sps
float64 0.2
99.2
⌀ | aps
float64 0
143
⌀ | surv2m
float64 0
0.97
⌀ | surv6m
float64 0
0.95
⌀ | hday
int64 1
148
| diabetes
int64 0
1
| dementia
int64 0
1
| ca
stringclasses 3
values | prg2m
float64 0
1
⌀ | prg6m
float64 0
1
⌀ | dnr
stringclasses 3
values | dnrday
float64 -88
285
⌀ | meanbp
float64 0
195
⌀ | wblc
float64 0
200
⌀ | hrt
float64 0
300
⌀ | resp
float64 0
90
⌀ | temp
float64 31.7
41.7
⌀ | pafi
float64 12
890
⌀ | alb
float64 0.4
29
⌀ | bili
float64 0.1
63
⌀ | crea
float64 0.1
21.5
⌀ | sod
float64 110
181
⌀ | ph
float64 6.83
7.77
⌀ | glucose
float64 0
1.09k
⌀ | bun
float64 1
300
⌀ | urine
float64 0
9k
⌀ | adlp
float64 0
7
⌀ | adls
float64 0
7
⌀ | sfdm2
stringclasses 5
values | adlsc
float64 0
7.07
| event_times
int64 3
2.03k
| event_indicators
int64 0
1
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
66.16595
|
female
| 0
| 10
|
Colon Cancer
|
Cancer
| 1
| null | null | 0
| 13,752
| 10,945.625
| 10,203.4297
| 20
|
white
| 16.398438
| 16
| 0.822998
| 0.616943
| 1
| 0
| 0
|
metastatic
| 1
| 0.8
|
no dnr
| 10
| 106
| 12.298828
| 106
| 20
| 36.19531
| null | 2.199707
| 0.5
| 0.699951
| 135
| null | null | null | null | null | null | null | 2.678711
| 890
| 1
|
74.02295
|
female
| 1
| 5
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| null |
under $11k
| 0
| 20,338
| 17,173.6562
| 16,354.0391
| 11
|
white
| 25.097656
| 22
| 0.697998
| 0.533936
| 9
| 0
| 0
|
no
| null | null |
dnr after sadm
| 2
| 61
| 16.097656
| 54
| 22
| 34.89844
| null | null | null | 0.799927
| 131
| null | null | null | null | null | null |
<2 mo. follow-up
| 2.818848
| 5
| 1
|
77.62897
|
female
| 0
| 4
|
Lung Cancer
|
Cancer
| 3
| 12
|
under $11k
| 0
| 2,329
| 1,721.9814
| 486.50977
| 10
|
white
| 12.798828
| 24
| 0.757935
| 0.50293
| 1
| 0
| 0
|
metastatic
| null | null |
dnr after sadm
| 1
| 63
| 3.899902
| 86
| 28
| 36.19531
| 296
| 3.899902
| 0.299988
| 0.699951
| 136
| 7.389648
| null | null | null | null | null | null | 2.87793
| 403
| 1
|
63.159
|
male
| 0
| 10
|
Lung Cancer
|
Cancer
| 3
| 2
|
under $11k
| 0
| 6,314
| 4,904.9883
| 4,245.51953
| 5.5
|
white
| 22.796875
| 14
| 0.580933
| 0.260986
| 1
| 0
| 0
|
metastatic
| 0.9
| 0.5
|
dnr after sadm
| 8
| 65
| 7
| 94
| 21
| 36.09375
| null | 3.199707
| 0.5
| 0.799927
| 130
| null | null | null | null | 4
| 6
|
no(M2 and SIP pres)
| 6
| 114
| 1
|
61.95999
|
female
| 0
| 8
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
|
$11-$25k
| 0
| 14,632
| 12,260.9844
| 11,042.5781
| 16.5
|
white
| 30.296875
| 28
| 0.713989
| 0.62793
| 1
| 0
| 0
|
no
| 0.9
| 0.85
|
dnr after sadm
| 4
| 72
| 3.399902
| 118
| 32
| 36.79688
| 520.875
| 2.599609
| 0.299988
| 0.099991
| 135
| 7.389648
| null | null | null | 6
| 6
|
adl>=4 (>=5 if sur)
| 6
| 1,810
| 0
|
74.38696
|
female
| 1
| 11
|
MOSF w/Malig
|
ARF/MOSF
| 3
| 12
|
under $11k
| 9
| 11,969
| 8,219.4922
| 8,524.78906
| 32
|
white
| 37.195313
| 54
| 0.200989
| 0.107986
| 1
| 0
| 0
|
metastatic
| 0.5
| 0.5
|
no dnr
| 11
| 110
| 0
| 108
| 30
| 36
| null | 2
| 1.099854
| 1.799805
| 127
| null | null | null | null | 7
| 6
|
<2 mo. follow-up
| 6
| 11
| 1
|
53.46997
|
male
| 1
| 31
|
Lung Cancer
|
Cancer
| 1
| 13
|
$25-$50k
| 100
| 64,508
| 45,421.3438
| 47,679.9688
| 40
|
other
| 18.398438
| 16
| 0.190979
| 0.016998
| 3
| 0
| 0
|
metastatic
| 0.2
| 0.1
|
dnr after sadm
| 15
| 142
| 11
| 68
| 10
| 38.19531
| 300
| 3.099609
| 0.799927
| 0.899902
| 138
| 7.5
| null | null | null | null | 1
|
<2 mo. follow-up
| 1
| 31
| 1
|
64.31995
|
female
| 1
| 10
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 7
|
under $11k
| 44
| 49,996
| 34,270.7188
| 34,682.0312
| 58.5
|
black
| 31.398438
| 51
| 0.376953
| 0.258972
| 11
| 0
| 0
|
no
| 0.25
| 0.25
|
dnr after sadm
| 10
| 47
| 28
| 79
| 8
| 35.39844
| 166
| 2.399902
| 0.799927
| 1.299805
| 134
| 7.319336
| null | null | null | null | 6
|
<2 mo. follow-up
| 6
| 10
| 1
|
25.56899
|
female
| 0
| 8
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 11
|
under $11k
| 0
| 10,774
| 8,177.8164
| 8,215.79688
| 14.5
|
white
| 21.898438
| 27
| 0.919922
| 0.865967
| 3
| 0
| 0
|
no
| 0.9
| 0.9
|
no dnr
| 8
| 106
| 11.099609
| 113
| 26
| 37.5
| null | null | 2.199707
| 1.299805
| 136
| null | null | null | null | 3
| 2
|
no(M2 and SIP pres)
| 2
| 1,808
| 0
|
90.79297
|
female
| 0
| 5
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| 10
|
under $11k
| 0
| 3,583
| 2,672.3301
| 2,389.16992
| 15
|
black
| 18
| 31
| 0.751953
| 0.608887
| 1
| 0
| 0
|
yes
| 0.9
| 0.8
|
dnr after sadm
| 4
| 114
| 5.599609
| 104
| 24
| 36.39844
| 285.6875
| null | 0.399963
| 1.399902
| 136
| 7.289062
| null | null | null | 3
| 1
|
no(M2 and SIP pres)
| 1
| 1,806
| 0
|
49.34198
|
female
| 0
| 14
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 13
|
>$50k
| 9
| 21,761
| 16,395.3594
| 15,894.8984
| 25.666656
|
white
| 34
| 68
| 0.666992
| 0.570923
| 1
| 0
| 0
|
no
| 0.6
| 0.6
|
no dnr
| 14
| 115
| 19
| 75
| 32
| 35.79688
| 208
| 2.699707
| 19.597656
| 7.399414
| 138
| 7.269531
| null | null | null | null | 1
|
no(M2 and SIP pres)
| 1
| 1,807
| 0
|
28.674
|
male
| 0
| 42
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 0
|
under $11k
| 44
| 41,966
| 31,984.6875
| 30,799.4219
| 30
|
black
| 23.597656
| 25
| 0.823975
| 0.764893
| 1
| 0
| 0
|
no
| 0.2
| 0.05
|
no dnr
| 42
| 71
| 15.398438
| 113
| 28
| 39.09375
| 223.96875
| 2.599609
| 2.899902
| 0.799927
| 136
| 7.399414
| null | null | null | null | null |
adl>=4 (>=5 if sur)
| 2.799805
| 122
| 1
|
40.67398
|
male
| 0
| 18
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
| null | 0
| 32,228
| 26,405.9688
| 24,254.6562
| 25
|
white
| 29.5
| 44
| 0.81189
| 0.748901
| 1
| 0
| 0
|
no
| 0.5
| 0.45
|
no dnr
| 18
| 81
| 18.5
| 104
| 32
| 38.19531
| 118.32812
| 2.799805
| 1
| 8.898438
| 137
| 7.289062
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 1,805
| 0
|
61.20499
|
male
| 0
| 21
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| null |
under $11k
| 0
| 24,785
| 19,240.0938
| 19,142.0781
| 22.666656
|
white
| 35.695313
| 53
| 0.5979
| 0.48999
| 1
| 0
| 0
|
no
| 0.75
| 0.6
|
dnr after sadm
| 14
| 75
| 17.097656
| 120
| 24
| 36.39844
| 149.96875
| 2.799805
| 17.296875
| 0.699951
| 136
| 7.439453
| null | null | null | 1
| 0
|
no(M2 and SIP pres)
| 0
| 1,805
| 0
|
78.25897
|
female
| 1
| 9
|
COPD
|
COPD/CHF/Cirrhosis
| 1
| null |
under $11k
| 0
| 24,767
| 20,170.4375
| 18,509.7188
| 43
|
white
| 34.59375
| 73
| 0.470947
| 0.268982
| 1
| 0
| 0
|
no
| 0.5
| 0.4
|
dnr after sadm
| 9
| 67
| 27.5
| 172
| 40
| 37.89844
| 145
| 2.899902
| 0.699951
| 1.099854
| 135
| 7.199219
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 9
| 1
|
57.10098
|
female
| 1
| 9
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 10
| null | 37
| 15,277
| 10,335.9844
| 10,889.4688
| 22
|
white
| 28.597656
| 20
| 0.266968
| 0.16098
| 5
| 0
| 0
|
metastatic
| 0.5
| 0.5
|
dnr after sadm
| 1
| 68
| 12.699219
| 68
| 22
| 36.19531
| 169.5625
| 3.099609
| 0.799927
| 0.399963
| 127
| 7.459961
| null | null | null | null | 6
|
<2 mo. follow-up
| 6
| 9
| 1
|
70.67798
|
male
| 0
| 15
|
COPD
|
COPD/CHF/Cirrhosis
| 5
| 10
|
under $11k
| 0
| 27,689
| 22,611.8906
| 20,786.0781
| 28.333328
|
white
| 26.199219
| 30
| 0.688965
| 0.522949
| 1
| 0
| 0
|
yes
| 0.4
| 0.35
|
no dnr
| 15
| 128
| 11.099609
| 136
| 36
| 38.29688
| 323.3125
| 2.799805
| 0.599976
| 0.599976
| 130
| 7.40918
| null | null | null | null | 7
|
adl>=4 (>=5 if sur)
| 7
| 82
| 1
|
76.13397
|
male
| 0
| 21
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 8
|
$11-$25k
| 0
| 25,041
| 19,356.9375
| 17,746.7656
| 17
|
white
| 24.796875
| 37
| 0.728882
| 0.575928
| 1
| 0
| 0
|
no
| 0.7
| 0.5
|
no dnr
| 21
| 106
| 23.398438
| 109
| 8
| 37.89844
| 61.09375
| 4.299805
| 1
| 1.299805
| 136
| 7.219727
| null | null | null | null | null |
adl>=4 (>=5 if sur)
| 3.283203
| 1,803
| 0
|
42.034
|
male
| 0
| 21
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 4
| 12
|
under $11k
| 0
| 21,258
| 16,261.6641
| 15,196.5391
| 17
|
black
| 30.699219
| 42
| 0.721924
| 0.566895
| 1
| 0
| 0
|
no
| 0.7
| 0.7
|
no dnr
| 21
| 82
| 30
| 122
| 26
| 37.79688
| 476
| 2.699707
| 7.599609
| 0.5
| 143
| 7.329102
| null | null | null | null | 7
|
no(M2 and SIP pres)
| 7
| 451
| 1
|
61.69998
|
male
| 0
| 6
|
Lung Cancer
|
Cancer
| 3
| 4
|
under $11k
| 0
| 5,497
| 3,823.4199
| 3,962.20898
| 14
|
black
| 24.699219
| 29
| 0.535889
| 0.213989
| 1
| 0
| 0
|
metastatic
| 0.5
| 0.4
|
dnr after sadm
| 2
| 93
| 15.298828
| 112
| 24
| 37.5
| 233.3125
| 3.599609
| 0.599976
| 0.5
| 127
| 7.40918
| null | null | null | 6
| 5
|
<2 mo. follow-up
| 5
| 12
| 1
|
34.21997
|
female
| 0
| 20
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
|
under $11k
| 0
| 26,755
| 21,557.2812
| 19,361.2656
| 28
|
black
| 26.699219
| 54
| 0.863892
| 0.815918
| 1
| 1
| 0
|
no
| 0.7
| 0.65
|
no dnr
| 20
| 107
| 14
| 154
| 20
| 38.5
| 321.625
| 2.899902
| 0.899902
| 5
| 143
| 7.289062
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 1,801
| 0
|
48.71198
|
male
| 0
| 52
|
MOSF w/Malig
|
ARF/MOSF
| 2
| null | null | 0
| 80,965
| 60,449.4688
| 60,074.0938
| 39.25
|
black
| 28.296875
| 60
| 0.494995
| 0.376953
| 4
| 0
| 0
|
metastatic
| 0.35
| 0.3
|
no dnr
| 52
| 63
| 16.898438
| 141
| 48
| 39.69531
| 308.5625
| 2.399902
| 0.399963
| 2.099609
| 135
| 7.25
| null | null | null | null | null |
Coma or Intub
| 3.120117
| 942
| 1
|
37.66699
|
male
| 0
| 10
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 7
|
under $11k
| 0
| 8,869
| 6,339.2773
| 6,359.57812
| 14
|
white
| 20.699219
| 21
| 0.907959
| 0.875
| 1
| 0
| 0
|
no
| 0.98
| 0.95
|
no dnr
| 10
| 103
| 10.099609
| 106
| 26
| 37.39844
| 240
| 2.5
| 0.5
| 0.5
| 140
| 7.399414
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,798
| 0
|
80.40198
|
female
| 0
| 14
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 8
|
under $11k
| 0
| 19,842
| 15,220.7266
| 14,714.0547
| 31.333328
|
white
| 20.199219
| 32
| 0.80896
| 0.744995
| 1
| 1
| 0
|
no
| 0.5
| 0.3
|
no dnr
| 14
| 101
| 9.699219
| 69
| 30
| 36
| 367.125
| 4
| 0.599976
| 1.399902
| 132
| 7.339844
| null | null | null | 1
| 2
|
no(M2 and SIP pres)
| 2
| 1,598
| 1
|
54.58197
|
male
| 0
| 28
|
CHF
|
COPD/CHF/Cirrhosis
| 5
| 10
|
under $11k
| 0
| 35,406
| 16,886.2656
| 15,097.5234
| 16.25
|
white
| 28.296875
| 34
| 0.792969
| 0.666992
| 1
| 1
| 0
|
no
| 0.9
| 0.9
|
no dnr
| 28
| 69
| 14.099609
| 115
| 24
| 35
| 289
| 2.5
| 1.299805
| 1.399902
| 134
| 7.40918
| null | null | null | 1
| null | null | 1.1669
| 788
| 1
|
60.28198
|
male
| 1
| 4
|
Coma
|
Coma
| 1
| 12
| null | 61
| 8,966
| 6,013.7773
| 6,082.54688
| 25
|
white
| 25.398438
| 29
| 0.385986
| 0.312988
| 2
| 0
| 0
|
no
| 0.03
| 0.000027
|
dnr after sadm
| 2
| 114
| 17.398438
| 57
| 8
| 38
| 102.84375
| null | null | 1.5
| 137
| 7.55957
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 4
| 1
|
78.23096
|
female
| 0
| 14
|
Lung Cancer
|
Cancer
| 4
| 8
|
under $11k
| 0
| 13,297
| 9,301.0312
| 10,425.2969
| 14.333328
|
white
| 20.296875
| 34
| 0.599976
| 0.281982
| 1
| 1
| 0
|
metastatic
| 0.8
| 0.7
|
no dnr
| 14
| 117
| 11.5
| 74
| 30
| 39.09375
| 274.25
| 2.699707
| 0.97998
| 0.699951
| 134
| 7.40918
| null | null | null | 2
| 1
|
no(M2 and SIP pres)
| 1
| 1,796
| 0
|
63.461
|
female
| 0
| 7
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 4
| 8
|
under $11k
| 37
| 13,104
| 11,109.5781
| 10,091.5859
| 23
|
black
| 31.796875
| 60
| 0.512939
| 0.396973
| 1
| 1
| 0
|
no
| 0.7
| 0.5
|
dnr after sadm
| 1
| 61
| 25.796875
| 107
| 36
| 36.19531
| 355.5
| 2.199707
| 1.599854
| 11.298828
| 125
| 7.379883
| null | null | null | null | 7
|
<2 mo. follow-up
| 7
| 39
| 1
|
46.03699
|
male
| 1
| 27
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| null | null | 0
| 93,619
| 64,251.2812
| 64,284
| 51.75
|
white
| 26.5
| 47
| 0.799927
| 0.733887
| 5
| 0
| 0
|
no
| 0.8
| 0.7
|
no dnr
| 27
| 111
| 4.399414
| 108
| 14
| 37.59375
| 191
| 1.899902
| 0.699951
| 2.099609
| 134
| 7.449219
| null | null | null | null | null |
<2 mo. follow-up
| 2.671875
| 27
| 1
|
70.44995
|
female
| 1
| 11
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 11
|
$11-$25k
| 26
| 13,830
| 10,619.9219
| 9,923.04688
| 23.5
|
white
| 28.699219
| 55
| 0.603882
| 0.496948
| 1
| 1
| 1
|
no
| 0.8
| 0.6
|
dnr after sadm
| 4
| 126
| 22
| 130
| 24
| 37.59375
| 480.9375
| 2.199707
| 2.599609
| 3.699707
| 141
| 7.399414
| null | null | null | null | 7
|
<2 mo. follow-up
| 7
| 11
| 1
|
60.93399
|
female
| 0
| 5
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 7
|
under $11k
| 0
| 4,762
| 3,383.1133
| 2,993.99805
| 13
|
hispanic
| 17.398438
| 26
| 0.895996
| 0.825928
| 1
| 0
| 0
|
no
| 0.95
| 0.9
|
no dnr
| 5
| 74
| 10.199219
| 100
| 16
| 36.09375
| 409.5
| 3.699707
| 0.799927
| 1.299805
| 137
| 7.429688
| null | null | null | 0
| 1
|
no(M2 and SIP pres)
| 1
| 1,792
| 0
|
38.32397
|
female
| 0
| 12
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 12
|
under $11k
| 0
| 27,923
| 21,899.0938
| 21,813.3438
| 48
|
white
| 29.097656
| 43
| 0.823975
| 0.764893
| 1
| 0
| 0
|
no
| 0.5
| 0.3
|
no dnr
| 12
| 120
| null | 114
| 40
| 38.09375
| 111.65625
| 2.699707
| 4.099609
| 0.899902
| 137
| 7.459961
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 683
| 1
|
51.72098
|
male
| 0
| 37
|
MOSF w/Malig
|
ARF/MOSF
| 2
| 11
|
$11-$25k
| 61
| 71,184
| 55,309.4375
| 54,298
| 36.75
|
black
| 43.195313
| 107
| 0.021999
| 0.004999
| 1
| 0
| 0
|
yes
| 0
| 0
|
dnr after sadm
| 8
| 55
| 0.119995
| 164
| 58
| 38.5
| 205
| 2.799805
| 0.599976
| 5.099609
| 133
| 7.299805
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 274
| 1
|
46.60098
|
male
| 0
| 9
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 2
| 12
|
under $11k
| 0
| 6,502
| 4,792.9609
| 4,722.82812
| 7.5
|
white
| 32
| 43
| 0.659912
| 0.483948
| 1
| 0
| 0
|
no
| 0.75
| 0.6
|
no dnr
| 9
| 83
| 8.699219
| 120
| 24
| 39.79688
| 314.25
| 2.399902
| 23.199219
| 1
| 129
| 7.489258
| null | null | null | 0
| 2
|
SIP>=30
| 2
| 745
| 1
|
71.39795
|
female
| 1
| 3
|
Coma
|
Coma
| 1
| 8
| null | 100
| 9,371
| 7,837.5391
| 7,230.20703
| 37
|
white
| 29.199219
| 72
| 0.043999
| 0.021999
| 2
| 0
| 0
|
no
| 0
| 0
|
dnr after sadm
| 2
| 141
| 30.5
| 167
| 0
| 35.79688
| 375.5
| null | 1
| 0.799927
| 140
| 7.339844
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 3
| 1
|
50.98999
|
male
| 0
| 18
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 2
| 12
|
under $11k
| 26
| 35,167
| 26,106.5469
| 26,240.1562
| 15
|
black
| 16.699219
| 26
| 0.760986
| 0.620972
| 15
| 0
| 0
|
no
| 0.9
| 0.9
|
no dnr
| 18
| 120
| 5.899414
| 81
| 24
| 36.79688
| 380.9375
| 2.399902
| 2.5
| 0.599976
| 141
| 7.489258
| null | null | null | 0
| null |
no(M2 and SIP pres)
| 0.4948
| 695
| 1
|
64.97998
|
female
| 0
| 51
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 9
|
under $11k
| 0
| 79,752
| 61,106.6562
| 66,229.375
| 33.5
|
black
| 30.796875
| 67
| 0.588989
| 0.480957
| 22
| 1
| 0
|
no
| 0.5
| 0.4
|
no dnr
| 51
| 151
| 8.699219
| 122
| 48
| 35.79688
| null | 2.799805
| 3.599609
| 2.599609
| 142
| 7.379883
| null | null | null | null | 6
| null | 6
| 82
| 1
|
60.44098
|
male
| 0
| 142
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 4
| null |
under $11k
| 89
| 215,368
| 147,888.75
| 153,348.625
| 47.25
|
white
| 21.699219
| 40
| 0.55896
| 0.44696
| 1
| 1
| 0
|
no
| 0.01
| 0.000001
|
no dnr
| 142
| 61
| 17.898438
| 66
| 10
| 38.09375
| 150
| 1.599854
| 0.5
| 1.799805
| 142
| 7.30957
| null | null | null | null | null |
adl>=4 (>=5 if sur)
| 4.3125
| 435
| 1
|
29.37199
|
female
| 0
| 4
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
|
under $11k
| 0
| 8,842
| 7,442.1211
| 7,271.27734
| 36
|
white
| 30.199219
| 39
| 0.836914
| 0.780884
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 4
| 76
| 8.5
| 64
| 44
| 36.19531
| 206.65625
| 2.399902
| 3.299805
| 0.5
| 124
| 7.439453
| null | null | null | 5
| null |
SIP>=30
| 3.855299
| 1,788
| 0
|
56.77499
|
female
| 0
| 7
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
|
under $11k
| 55
| 11,870
| 9,637.2969
| 9,996.03906
| 25
|
hispanic
| 30.699219
| 49
| 0.498962
| 0.381958
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 7
| 63
| 10.898438
| 120
| 12
| 35.5
| 576
| 3.399902
| 1.699951
| 2.5
| 139
| 7.40918
| null | null | null | null | 5
|
adl>=4 (>=5 if sur)
| 5
| 478
| 1
|
38.51297
|
male
| 0
| 5
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 12
|
$11-$25k
| 0
| 3,277
| 2,470.75
| 2,119
| 6
|
black
| 24.097656
| 18
| 0.890991
| 0.817993
| 1
| 0
| 0
|
no
| 1
| 0.95
|
no dnr
| 5
| 83
| 11.199219
| 78
| 28
| 35.39844
| null | 3.099609
| 0.799927
| 1.099854
| 134
| null | null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,265
| 1
|
60.504
|
female
| 0
| 6
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 10
|
under $11k
| 0
| 4,814
| 3,455.4551
| 3,256.42969
| 4
|
black
| 10.398438
| 16
| 0.939941
| 0.897949
| 1
| 0
| 0
|
no
| 1
| 1
|
no dnr
| 6
| 63
| 5
| 76
| 22
| 37
| 317.5625
| 4
| 0.5
| 0.799927
| 141
| 7.389648
| null | null | null | 2
| 0
|
no(M2 and SIP pres)
| 0
| 1,786
| 0
|
66.89697
|
female
| 0
| 11
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 1
|
under $11k
| 0
| 9,648
| 7,119.8281
| 7,129.34766
| 8.5
|
white
| 29.699219
| 23
| 0.702881
| 0.613892
| 1
| 1
| 0
|
no
| 0.85
| 0.7
|
no dnr
| 11
| 107
| 9.398438
| 55
| 22
| 35.59375
| 390.75
| 3.299805
| 2
| 0.5
| 123
| 7.429688
| null | null | null | 1
| 0
| null | 0
| 1,783
| 0
|
77.20496
|
male
| 0
| 15
|
MOSF w/Malig
|
ARF/MOSF
| 4
| 9
|
under $11k
| 9
| 17,320
| 13,018.6016
| 12,415.1172
| 10.666664
|
white
| 26
| 33
| 0.491943
| 0.373962
| 2
| 0
| 1
|
metastatic
| 0.7
| 0.5
|
no dnr
| 15
| 101
| 5
| 60
| 22
| 36
| null | null | null | 2.099609
| 131
| null | null | null | null | null | 6
|
adl>=4 (>=5 if sur)
| 6
| 139
| 1
|
65.19397
|
male
| 1
| 52
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 11
| null | 9
| 95,928
| 149,235.375
| 145,356.375
| 49.75
|
white
| 32.898438
| 76
| 0.549927
| 0.436951
| 4
| 0
| 0
|
no
| 0.5
| 0.5
|
dnr after sadm
| 31
| 140
| 7.799805
| 160
| 50
| 38.39844
| 66.65625
| 2.599609
| 2.099609
| 1.399902
| 138
| 7.359375
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 52
| 1
|
58.71597
|
male
| 0
| 7
|
CHF
|
COPD/CHF/Cirrhosis
| 7
| 9
|
under $11k
| 0
| 5,241
| 3,779.2324
| 3,529.80859
| 6
|
white
| 11.898438
| 13
| 0.934937
| 0.889893
| 1
| 0
| 0
|
no
| 0.8
| 0.7
|
no dnr
| 7
| 117
| 11.398438
| 76
| 24
| 35.79688
| 345.6875
| 4.299805
| 0.5
| 1.199951
| 137
| 7.359375
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 409
| 1
|
39.53998
|
male
| 0
| 15
|
MOSF w/Malig
|
ARF/MOSF
| 3
| 12
|
under $11k
| 0
| 14,958
| 10,852.5078
| 11,143.5547
| 12.666664
|
black
| 26.199219
| 44
| 0.640991
| 0.539917
| 4
| 0
| 0
|
yes
| 1
| 0.95
|
no dnr
| 15
| 68
| 0.799927
| 110
| 28
| 38.59375
| null | 3.199707
| 0.699951
| 1.099854
| 136
| null | null | null | null | 1
| null |
no(M2 and SIP pres)
| 1.1669
| 137
| 1
|
77.09198
|
male
| 0
| 12
|
Colon Cancer
|
Cancer
| 1
| null | null | 0
| 8,254
| 6,119.1133
| 6,220.46875
| 17.5
|
white
| 14.398438
| 27
| 0.829956
| 0.628906
| 1
| 0
| 0
|
metastatic
| 0.85
| 0.7
|
no dnr
| 12
| 76
| 1.5
| 72
| 20
| 36.5
| null | 3.599609
| 1.299805
| 1.399902
| 137
| null | null | null | null | null | null |
no(M2 and SIP pres)
| 2.811523
| 228
| 1
|
63.35397
|
female
| 0
| 6
|
Lung Cancer
|
Cancer
| 2
| 12
|
under $11k
| 0
| 5,825
| 4,132.4453
| 4,908.55859
| 12
|
white
| 9.599609
| 16
| 0.829956
| 0.629883
| 1
| 0
| 0
|
metastatic
| 0.95
| 0.75
|
no dnr
| 6
| 95
| 18.597656
| 100
| 28
| 36.69531
| null | 4.399414
| 0.599976
| 0.799927
| 141
| null | null | null | null | 1
| 1
|
SIP>=30
| 1
| 570
| 1
|
69.07898
|
female
| 1
| 30
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 4
| 10
|
$11-$25k
| 0
| 58,852
| 42,840.1562
| 43,494.8438
| 25.5
|
white
| 28.5
| 43
| 0.716919
| 0.629883
| 1
| 0
| 0
|
no
| 0.5
| 0.2
|
dnr after sadm
| 8
| 64
| 7.299805
| 116
| 24
| 35.19531
| 220
| 4.699219
| 0.799927
| 6.099609
| 135
| 7.319336
| null | null | null | null | null |
<2 mo. follow-up
| 3.978516
| 30
| 1
|
64.79095
|
female
| 0
| 25
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
|
under $11k
| 0
| 25,943
| 19,867.2188
| 19,136.7656
| 17.5
|
white
| 19.296875
| 28
| 0.86499
| 0.816895
| 1
| 0
| 0
|
no
| 0.8
| 0.6
|
no dnr
| 25
| 114
| 10
| 100
| 28
| 38.09375
| 188
| null | 0.5
| 1.299805
| 139
| 7.389648
| null | null | null | null | 4
|
adl>=4 (>=5 if sur)
| 4
| 1,778
| 0
|
40.54999
|
male
| 0
| 11
|
Coma
|
Coma
| 1
| 12
|
$11-$25k
| 9
| 31,993
| 23,123.7188
| 24,286.0938
| 25
|
white
| 18.398438
| 7
| 0.843994
| 0.81189
| 6
| 0
| 0
|
no
| 0.95
| 0.92
|
no dnr
| 11
| 107
| 13
| 57
| 12
| 36.79688
| 416.625
| 4.199219
| 0.799927
| 0.699951
| 137
| 7.419922
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 1,777
| 0
|
68.03296
|
female
| 1
| 62
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 4
| 12
|
under $11k
| 0
| 152,535
| 108,015.625
| 105,496.688
| 51.25
|
white
| 30.199219
| 36
| 0.606934
| 0.500977
| 10
| 1
| 0
|
no
| 0.3
| 0.2
|
dnr after sadm
| 59
| 67
| 24.597656
| 130
| 36
| 36.5
| 161.40625
| null | null | 0.599976
| 136
| 7.489258
| null | null | null | 7
| null | null | 5.199497
| 62
| 1
|
65.23999
|
female
| 1
| 15
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 11
|
under $11k
| 0
| 73,712
| 49,551.5
| 49,817.1875
| 46.666657
|
white
| 25.597656
| 52
| 0.574951
| 0.464966
| 17
| 0
| 0
|
metastatic
| 0.5
| 0.5
|
dnr after sadm
| 11
| 71
| 30.296875
| 116
| 28
| 36.89844
| 218.3125
| 1.899902
| 3.899902
| 0.899902
| 135
| 7.389648
| null | null | null | null | 7
|
<2 mo. follow-up
| 7
| 15
| 1
|
80.383
|
male
| 1
| 14
|
MOSF w/Malig
|
ARF/MOSF
| 2
| 8
| null | 0
| 66,713
| 51,143.25
| 50,021.1875
| 58
|
white
| 40.796875
| 70
| 0.112991
| 0.048996
| 23
| 0
| 0
|
yes
| 0.8
| 0.6
|
dnr after sadm
| 11
| 64
| 2.399902
| 114
| 32
| 38.59375
| 114
| 2.299805
| 4.799805
| 2.799805
| 138
| 7.329102
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 14
| 1
|
79.79199
|
female
| 0
| 7
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
|
under $11k
| 0
| 10,283
| 7,498.4453
| 7,438.09766
| 23
|
black
| 24
| 20
| 0.721924
| 0.636963
| 3
| 0
| 0
|
no
| 0.6
| 0.4
|
no dnr
| 7
| 101
| 11.798828
| 116
| 24
| 36.79688
| 321.1875
| 2.799805
| 0.5
| 0.599976
| 131
| 7.319336
| null | null | null | null | 6
| null | 6
| 658
| 1
|
40.93399
|
female
| 0
| 5
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 2
| 14
|
$11-$25k
| 0
| 8,101
| 6,421.1484
| 7,010.71875
| 16
|
other
| 19.597656
| 17
| 0.879883
| 0.799927
| 1
| 0
| 0
|
no
| 0.95
| 0.95
|
no dnr
| 5
| 74
| 4
| 113
| 14
| 36.69531
| 595.125
| 3.399902
| 1.5
| 0.799927
| 135
| 7.509766
| null | null | null | 6
| 5
|
no(M2 and SIP pres)
| 5
| 1,776
| 0
|
32.50699
|
male
| 0
| 15
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 3
| 13
|
$11-$25k
| 0
| 13,892
| 10,281.625
| 9,194.67969
| 11
|
white
| 17.699219
| 14
| 0.917969
| 0.861938
| 1
| 0
| 0
|
no
| 0.8
| 0.7
|
no dnr
| 15
| 93
| 4.899414
| 80
| 14
| 36
| null | 3.699707
| 2.399902
| 0.699951
| 140
| null | null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 136
| 1
|
58.40097
|
female
| 0
| 7
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 4
| 14
|
under $11k
| 0
| 5,292
| 3,863.125
| 3,674.46875
| 9
|
white
| 21.5
| 30
| 0.777954
| 0.644897
| 1
| 1
| 0
|
no
| 0.5
| 0.5
|
no dnr
| 7
| 99
| 3.299805
| 80
| 20
| 36.19531
| null | 2.699707
| 0.699951
| 3.699707
| 135
| null | null | null | null | 1
| null |
SIP>=30
| 1.1669
| 346
| 1
|
47.76498
|
female
| 0
| 7
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| null | null | 9
| 7,541
| 5,135.9883
| 4,902.51953
| 17
|
white
| 25
| 35
| 0.839966
| 0.737915
| 1
| 0
| 0
|
yes
| null | null |
no dnr
| 7
| 77
| 14.699219
| 126
| 32
| 35.59375
| 168.5625
| null | 0.899902
| 0.799927
| 138
| 7.279297
| null | null | null | null | null | null | 3.236816
| 1,774
| 0
|
61.72498
|
male
| 0
| 6
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| 11
|
$25-$50k
| 0
| 3,477
| 2,635.6445
| 2,312.25977
| 12
|
white
| 18.097656
| 13
| 0.888916
| 0.813965
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 6
| 99
| 6
| 68
| 24
| 35.59375
| 309.5
| 3.299805
| 1.299805
| 1.099854
| 141
| 7.389648
| null | null | null | null | null |
adl>=4 (>=5 if sur)
| 2.584473
| 1,177
| 1
|
36.99899
|
male
| 1
| 8
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
|
$11-$25k
| 44
| 40,579
| 34,104.3125
| 31,750.1875
| 30.5
|
white
| 49.398438
| 65
| 0.076996
| 0.028
| 17
| 0
| 0
|
no
| 0
| 0
|
dnr after sadm
| 4
| 69
| 14.099609
| 111
| 23
| 38.39844
| 127.26562
| 3.699707
| 63
| 5.599609
| 139
| 7.439453
| null | null | null | null | null |
<2 mo. follow-up
| 2.939453
| 8
| 1
|
58.28897
|
female
| 0
| 8
|
Lung Cancer
|
Cancer
| 1
| 16
|
under $11k
| 0
| 6,811
| 5,021.3906
| 4,500.87891
| 4.5
|
white
| 17.296875
| 18
| 0.717896
| 0.439941
| 1
| 0
| 0
|
metastatic
| 0.8
| 0.5
|
dnr after sadm
| 4
| 67
| 5.199219
| 106
| 16
| 38.19531
| null | 3.899902
| 1
| 0.399963
| 130
| null | null | null | null | 1
| 0
|
<2 mo. follow-up
| 0
| 25
| 1
|
86.72998
|
female
| 0
| 18
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 8
|
under $11k
| 0
| 19,233
| 15,117.0859
| 14,232.8672
| 26
|
white
| 31.699219
| 44
| 0.461975
| 0.342957
| 1
| 0
| 0
|
yes
| 0.8
| 0.8
|
no dnr
| 18
| 71
| 5
| 141
| 28
| 38.69531
| 220
| 2.899902
| 0.399963
| 0.399963
| 125
| 7.429688
| null | null | null | 4
| 6
|
no(M2 and SIP pres)
| 6
| 1,772
| 0
|
62.09399
|
female
| 0
| 17
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 8
| null | 0
| 14,936
| 10,613.7734
| 10,445.0469
| 13.333328
|
white
| 29.398438
| 37
| 0.670898
| 0.575928
| 1
| 0
| 0
|
yes
| 0.8
| 0.6
|
no dnr
| 17
| 122
| 13.398438
| 124
| 28
| 37.39844
| 203.3125
| 4.599609
| 1.299805
| 0.399963
| 131
| 7.399414
| null | null | null | null | 1
|
no(M2 and SIP pres)
| 1
| 1,771
| 0
|
49.10098
|
male
| 0
| 42
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
| null | 44
| 91,684
| 60,923.8125
| 61,644.8125
| 43.5
|
white
| 28
| 37
| 0.641968
| 0.540894
| 2
| 0
| 0
|
no
| 0.85
| 0.85
|
no dnr
| 42
| 67
| 21.199219
| 126
| 9
| 39.59375
| 177.5
| 2.099609
| 3.5
| 1.399902
| 145
| 7.509766
| null | null | null | null | 0
|
SIP>=30
| 0
| 1,769
| 0
|
68.14795
|
male
| 1
| 14
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 10
|
under $11k
| 0
| 32,717
| 24,427.875
| 24,427.75
| 39.666657
|
white
| 22.597656
| 36
| 0.792969
| 0.724976
| 3
| 0
| 0
|
no
| 0.5
| 0.4
|
dnr after sadm
| 11
| 113
| 17.699219
| 76
| 24
| 38.29688
| 182
| 2.799805
| 1.099854
| 2.599609
| 145
| 7.439453
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 14
| 1
|
64.87897
|
male
| 1
| 6
|
Coma
|
Coma
| 1
| 12
|
$25-$50k
| 100
| 18,925
| 13,683.5859
| 13,914.7969
| 62
|
white
| 40.59375
| 78
| 0.001
| 0
| 2
| 0
| 0
|
no
| 0.05
| 0.000125
|
dnr after sadm
| 6
| 65
| 14.298828
| 180
| 40
| 39.19531
| 146.25
| 2.299805
| 4.399414
| 3.399902
| 130
| 7.40918
| null | null | null | null | null |
<2 mo. follow-up
| 3.17627
| 6
| 1
|
53.55197
|
male
| 0
| 8
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 11
|
under $11k
| 0
| 19,763
| 15,451.3359
| 15,561.2344
| 26
|
white
| 29.898438
| 40
| 0.758911
| 0.681885
| 1
| 0
| 0
|
no
| 0.8
| 0.8
|
no dnr
| 8
| 70
| 10.099609
| 111
| 28
| 38.69531
| 122.84375
| 2.799805
| 2.899902
| 0.599976
| 147
| 7.449219
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 1,765
| 0
|
66.74298
|
female
| 0
| 101
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
|
$11-$25k
| 9
| 156,394
| 114,891.938
| 110,165.125
| 40.25
|
white
| 25.398438
| 37
| 0.754883
| 0.67688
| 1
| 0
| 0
|
no
| 0.85
| 0.85
|
dnr after sadm
| 44
| 71
| 10.898438
| 74
| 24
| 36
| 144.875
| 2.399902
| 2.699707
| 1.599854
| 139
| 7.389648
| null | null | null | 6
| 5
|
SIP>=30
| 5
| 1,764
| 0
|
19.351
|
male
| 0
| 11
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
|
$11-$25k
| 0
| 139,899
| 98,136.8125
| 96,743.875
| 18.5
|
white
| 31.597656
| 38
| 0.784912
| 0.714966
| 47
| 0
| 0
|
no
| 0.7
| 0.7
|
no dnr
| 11
| 71
| 15.898438
| 152
| 30
| 39.59375
| 210
| 3
| 0.5
| 0.299988
| 128
| 7.449219
| null | null | null | null | 0
|
adl>=4 (>=5 if sur)
| 0
| 1,763
| 0
|
64.85095
|
male
| 1
| 58
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 8
|
under $11k
| 44
| 214,606
| 147,583.875
| 148,627.875
| 54
|
white
| 31.5
| 62
| 0.360962
| 0.242981
| 15
| 0
| 0
|
no
| 0.5
| 0.5
|
dnr after sadm
| 45
| 67
| 18.296875
| 48
| 28
| 38.19531
| 132.375
| 2.399902
| 2.399902
| 2.599609
| 143
| 7.509766
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 58
| 1
|
69.91394
|
male
| 0
| 3
|
Lung Cancer
|
Cancer
| 6
| null |
under $11k
| 0
| 4,052
| 2,795.0059
| 3,625.1582
| 9
|
white
| 18.398438
| 13
| 0.643921
| 0.335999
| 2
| 0
| 0
|
metastatic
| null | null |
no dnr
| 3
| 76
| 8
| 104
| 22
| 36.19531
| null | null | null | 0.799927
| 141
| null | null | null | null | null | 2
|
<2 mo. follow-up
| 2
| 42
| 1
|
34.905
|
female
| 0
| 4
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 1
| 12
|
under $11k
| 0
| 3,180
| 2,314.9434
| 1,156.22949
| 8
|
white
| 25.296875
| 22
| 0.843994
| 0.74292
| 1
| 0
| 0
|
no
| 0.5
| 0.5
|
no dnr
| 4
| 95
| 12.5
| 116
| 24
| 37
| null | 2.5
| 3.599609
| 0.5
| 134
| null | null | null | null | null | null |
no(M2 and SIP pres)
| 2.290527
| 217
| 1
|
56.46799
|
male
| 1
| 18
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| null | null | 9
| 53,228
| 41,687.2188
| 40,337.5625
| 44.666657
| null | 36.5
| 82
| 0.565918
| 0.454956
| 1
| 0
| 0
|
no
| 0.15
| 0.15
|
dnr after sadm
| 17
| 69
| 9.798828
| 138
| 32
| 38.19531
| 186.375
| 1.599854
| 14.599609
| 2.599609
| 133
| 7.419922
| null | null | null | null | null |
<2 mo. follow-up
| 3.189453
| 18
| 1
|
78.90997
|
female
| 1
| 7
|
Coma
|
Coma
| 0
| 5
| null | 61
| 13,488
| 10,996.8281
| 10,169.1094
| 31
|
white
| 21.199219
| 34
| 0.343994
| 0.270996
| 1
| 0
| 0
|
no
| 0
| 0
|
dnr before sadm
| -1
| 122
| 17.699219
| 116
| 20
| 39.09375
| 318
| 2.699707
| 0.399963
| 1.299805
| 151
| 7.399414
| null | null | null | null | 1
|
<2 mo. follow-up
| 1
| 7
| 1
|
48.715
|
female
| 0
| 28
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 14
| null | 9
| 38,119
| 30,093.0312
| 28,434.8594
| 33.75
|
white
| 24.796875
| 34
| 0.827881
| 0.768921
| 1
| 0
| 0
|
no
| 0.9
| 0.9
|
no dnr
| 28
| 61
| 14
| 68
| 26
| 35.29688
| 175
| 2.399902
| 0.599976
| 1.099854
| 151
| 7.229492
| null | null | null | null | 7
|
adl>=4 (>=5 if sur)
| 7
| 1,759
| 0
|
53.16098
|
female
| 1
| 56
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 4
| null | null | 0
| 203,235
| 161,786.875
| 153,861.125
| 52.5
|
white
| 33.09375
| 65
| 0.524902
| 0.409973
| 22
| 1
| 0
|
yes
| 0.25
| 0.25
|
dnr after sadm
| 56
| 63
| 19.296875
| 136
| 8
| 36.79688
| 234
| 1.599854
| 7.699219
| 2.799805
| 136
| 7.379883
| null | null | null | null | null |
<2 mo. follow-up
| 3.276856
| 56
| 1
|
41.418
|
female
| 1
| 7
|
Coma
|
Coma
| 1
| 14
|
under $11k
| 100
| 25,814
| 20,979.4375
| 19,544.2344
| 48
|
black
| 25.296875
| 60
| 0.324951
| 0.252991
| 6
| 0
| 0
|
no
| 0
| 0
|
dnr after sadm
| 5
| 59
| 16.796875
| 78
| 12
| 35.19531
| 271.375
| 1.5
| 0.599976
| 2.699707
| 133
| 7.279297
| null | null | null | null | 3
|
<2 mo. follow-up
| 3
| 7
| 1
|
42.67499
|
female
| 1
| 4
|
Coma
|
Coma
| 2
| 12
|
under $11k
| 100
| 7,940
| 6,883.0859
| 6,103.54688
| 14
|
black
| 39.5
| 73
| 0.052994
| 0.028
| 1
| 0
| 0
|
no
| 0
| 0
|
dnr after sadm
| 2
| 38
| 6.199219
| 153
| 10
| 36.59375
| 387.125
| 3.399902
| 0.799927
| 9
| 144
| 7.189453
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 4
| 1
|
82.88599
|
male
| 1
| 27
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| null | null | 44
| 35,067
| 27,143.7344
| 25,166.9531
| 27.25
|
white
| 20.097656
| 43
| 0.660889
| 0.562988
| 1
| 0
| 0
|
no
| 0.25
| 0.25
|
dnr after sadm
| 1
| 66
| 8.898438
| 71
| 12
| 38
| 246
| 2.699707
| 1.299805
| 2.299805
| 157
| 7.439453
| null | null | null | null | null |
<2 mo. follow-up
| 4.868164
| 27
| 1
|
63.49298
|
male
| 0
| 14
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 8
|
under $11k
| 0
| 28,506
| 22,617.5
| 21,181.6094
| 24
|
white
| 22.796875
| 36
| 0.827881
| 0.769897
| 1
| 0
| 0
|
no
| 0.8
| 0.8
|
no dnr
| 14
| 73
| 20.796875
| 114
| 12
| 38.19531
| 208.5625
| 2.199707
| 1.399902
| 1.799805
| 140
| 7.459961
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 1,752
| 0
|
64.41895
|
female
| 0
| 22
|
CHF
|
COPD/CHF/Cirrhosis
| 5
| 12
|
under $11k
| 0
| 38,784
| 31,622.9375
| 29,024.2344
| 36.333313
|
white
| 31.097656
| 49
| 0.696899
| 0.532959
| 1
| 0
| 0
|
no
| 0.5
| 0.5
|
dnr after sadm
| 14
| 133
| 8.699219
| 113
| 48
| 36.59375
| 122.5
| 2.699707
| 0.599976
| 0.899902
| 132
| 7.209961
| null | null | null | null | 7
| null | 7
| 64
| 1
|
38.98398
|
male
| 0
| 16
|
MOSF w/Malig
|
ARF/MOSF
| 2
| 14
|
under $11k
| 0
| 22,489
| 16,593.1719
| 15,599.1328
| 15
|
black
| 18.398438
| 27
| 0.724976
| 0.639893
| 7
| 1
| 0
|
metastatic
| 0.75
| 0.5
|
no dnr
| 16
| 109
| 25.699219
| 108
| 16
| 37.89844
| 434.25
| 1.799805
| 0.599976
| 0.799927
| 139
| 7.449219
| null | null | null | 1
| 0
|
no(M2 and SIP pres)
| 0
| 425
| 1
|
62.41199
|
female
| 1
| 9
|
MOSF w/Malig
|
ARF/MOSF
| 3
| 11
|
$11-$25k
| 89
| 13,175
| 10,220.5547
| 9,913.67969
| 24.5
|
white
| 22
| 37
| 0.252991
| 0.148987
| 1
| 1
| 0
|
metastatic
| 0.05
| 0.000125
|
dnr after sadm
| 5
| 61
| 20.699219
| 110
| 34
| 39.19531
| 388
| 2.899902
| 1.399902
| 1.299805
| 136
| 7.489258
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 9
| 1
|
56.22699
|
female
| 0
| 5
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 11
| null | 0
| 15,031
| 10,768.1172
| 10,405.0938
| 23
|
black
| 19.296875
| 9
| 0.67688
| 0.581909
| 9
| 0
| 0
|
metastatic
| 0.5
| 0.25
|
dnr after sadm
| 2
| 81
| 12.599609
| 106
| 24
| 36.5
| 304.75
| 2.799805
| 0.699951
| 1
| 136
| 7.469727
| null | null | null | 1
| 0
|
<2 mo. follow-up
| 0
| 37
| 1
|
60.82098
|
male
| 1
| 4
|
Coma
|
Coma
| 0
| 16
|
$25-$50k
| 100
| 3,746
| 2,563.1621
| 3,008.18945
| 16
|
white
| 26.898438
| 52
| 0.17099
| 0.11499
| 1
| 0
| 0
|
no
| 0.07
| 0.000343
|
dnr before sadm
| -1
| 127
| 16.796875
| 144
| 10
| 40.39844
| 288
| 3.299805
| 0.399963
| 1.199951
| 130
| 7.489258
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 4
| 1
|
59.96997
|
male
| 0
| 7
|
Colon Cancer
|
Cancer
| 1
| 7
|
under $11k
| 0
| 6,863
| 4,849.3125
| 6,283.87891
| 13
|
white
| 26.5
| 20
| 0.662964
| 0.360962
| 1
| 0
| 0
|
metastatic
| 0.3
| 0.15
|
no dnr
| 7
| 77
| 10.798828
| 84
| 22
| 36.79688
| 407.125
| 2.5
| 1.699951
| 0.699951
| 132
| 7.439453
| null | null | null | 1
| 0
|
<2 mo. follow-up
| 0
| 55
| 1
|
59.63898
|
male
| 0
| 12
|
Lung Cancer
|
Cancer
| 3
| 7
|
under $11k
| 0
| 7,860
| 5,982.418
| 5,864.00781
| 8
|
black
| 25.796875
| 22
| 0.511963
| 0.189972
| 1
| 0
| 0
|
metastatic
| 0.2
| 0.05
|
dnr before sadm
| -1
| 101
| 12.798828
| 56
| 16
| 36.19531
| 890.375
| 2.799805
| 0.299988
| 1.299805
| 158
| 7.419922
| null | null | null | null | 7
|
<2 mo. follow-up
| 7
| 18
| 1
|
27.44099
|
male
| 0
| 30
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 11
| null | 44
| 62,613
| 45,073.9062
| 45,688.5625
| 29.5
|
white
| 24.5
| 32
| 0.802979
| 0.737915
| 2
| 0
| 0
|
no
| 0.8
| 0.8
|
no dnr
| 30
| 75
| 7.099609
| 126
| 16
| 38.69531
| 157.5
| 1.699951
| 1.799805
| 0.699951
| 135
| 7.379883
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 1,747
| 0
|
76.73895
|
male
| 1
| 8
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
|
under $11k
| 44
| 18,471
| 15,439.2266
| 14,177.1328
| 27
|
white
| 35.695313
| 74
| 0.243988
| 0.141998
| 2
| 0
| 0
|
no
| 0.01
| 0.000001
|
dnr after sadm
| 3
| 72
| 22.199219
| 108
| 44
| 38.19531
| 112.32812
| 1.799805
| 2.599609
| 5.399414
| 146
| 7.449219
| null | null | null | null | null |
<2 mo. follow-up
| 3.124512
| 8
| 1
|
66.26099
|
female
| 0
| 19
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| null |
under $11k
| 9
| 20,285
| 15,411.9375
| 16,042.5859
| 17.666656
|
black
| 22.097656
| 28
| 0.807983
| 0.743896
| 1
| 1
| 0
|
no
| 0.9
| 0.7
|
no dnr
| 19
| 112
| 16.199219
| 69
| 16
| 35
| 495.1875
| 2.599609
| 0.299988
| 1.399902
| 151
| 7.349609
| null | null | null | null | 2
| null | 2
| 1,747
| 0
|
47.14899
|
male
| 0
| 7
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 5
| 9
| null | 0
| 7,390
| 5,705.2969
| 5,902.97656
| 8.5
|
hispanic
| 15.699219
| 17
| 0.893921
| 0.821899
| 1
| 0
| 0
|
no
| 0.75
| 0.7
|
no dnr
| 7
| 69
| 8.5
| 75
| 20
| 36
| 437.5625
| 3.199707
| 0.799927
| 1.099854
| 134
| 7.489258
| null | null | null | null | null |
SIP>=30
| 3.813477
| 209
| 1
|
51.04199
|
male
| 0
| 30
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 14
|
>$50k
| 0
| 52,045
| 35,465.7812
| 38,358.0312
| 28.5
|
white
| 32.898438
| 39
| 0.396973
| 0.277954
| 11
| 0
| 0
|
yes
| 0.7
| 0.3
|
no dnr
| 30
| 94
| 0
| 104
| 24
| 36.69531
| null | 2.5
| 3.199707
| 1.099854
| 127
| null | null | null | null | null | 0
|
SIP>=30
| 0
| 944
| 1
|
43.49298
|
female
| 0
| 7
|
CHF
|
COPD/CHF/Cirrhosis
| 6
| 12
|
$11-$25k
| 0
| 4,658
| 3,478.6856
| 3,603.80859
| 9
|
white
| 16.097656
| 16
| 0.934937
| 0.888916
| 1
| 1
| 0
|
no
| 0.4
| 0.3
|
dnr before sadm
| -1
| 60
| 8.898438
| 70
| 24
| 36.19531
| null | null | null | 1.199951
| 134
| null | null | null | null | 6
| 5
|
<2 mo. follow-up
| 5
| 40
| 1
|
54.63898
|
male
| 0
| 55
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 12
|
$25-$50k
| 0
| 19,172
| 40,448.4062
| 36,850.7188
| 19.75
|
white
| 24.398438
| 22
| 0.834961
| 0.777954
| 1
| 1
| 0
|
no
| 0.7
| 0.7
|
dnr after sadm
| 14
| 121
| 16.699219
| 130
| 24
| 36.29688
| 350
| 2.899902
| 0.699951
| 0.699951
| 133
| 7.429688
| null | null | null | null | 6
| null | 6
| 1,745
| 0
|
56.48999
|
male
| 0
| 3
|
Colon Cancer
|
Cancer
| 1
| 11
|
$11-$25k
| 0
| 1,837
| 1,393.9902
| 1,371.14941
| 13
|
black
| 13.699219
| 19
| 0.868896
| 0.705933
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 3
| 60
| 2.699707
| 70
| 22
| 36.5
| null | 3.699707
| 1.099854
| 0.899902
| 133
| null | null | null | null | null | null |
no(M2 and SIP pres)
| 1.918701
| 1,383
| 1
|
77.63397
|
male
| 0
| 72
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 8
|
$11-$25k
| 26
| 144,351
| 102,315.188
| 110,045
| 38.75
|
white
| 25.699219
| 49
| 0.519897
| 0.403992
| 26
| 0
| 0
|
no
| 0.5
| 0.5
|
no dnr
| 72
| 65
| 3.5
| 73
| 34
| 38.59375
| 183.21875
| 1.699951
| 2.899902
| 1.699951
| 145
| 7.429688
| null | null | null | null | 1
|
adl>=4 (>=5 if sur)
| 1
| 78
| 1
|
76.03796
|
male
| 0
| 4
|
Lung Cancer
|
Cancer
| 2
| null |
$25-$50k
| 9
| 2,028
| 1,553.627
| 1,575.21973
| 4
|
white
| 14.398438
| 14
| 0.700928
| 0.414978
| 1
| 0
| 0
|
metastatic
| 0.2
| 0
|
dnr before sadm
| -1
| 99
| 3.299805
| 64
| 16
| 36.19531
| null | 3.599609
| 0.399963
| 1.199951
| 136
| null | null | null | null | null | 6
|
adl>=4 (>=5 if sur)
| 6
| 236
| 1
|
68.48199
|
male
| 0
| 7
|
COPD
|
COPD/CHF/Cirrhosis
| 6
| 10
|
under $11k
| 0
| 11,045
| 8,732.6016
| 8,364.82812
| 31
|
white
| 25.898438
| 37
| 0.712891
| 0.554932
| 1
| 0
| 0
|
yes
| 0.75
| 0.7
|
no dnr
| 7
| 138
| 11.5
| 57
| 12
| 36.79688
| 224.46875
| 3.299805
| 1.099854
| 3
| 140
| 7.389648
| null | null | null | 0
| null |
no(M2 and SIP pres)
| 0.4948
| 910
| 1
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.